Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy Context Therapeutics Inc. (CNTX) stocks in Canada
Learn how to easily invest in Context Therapeutics Inc. stocks.
Context Therapeutics Inc. is a biotechnology business based in the US. Context Therapeutics Inc. stocks (CNTX.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $6.26 – a decrease of 6.67% over the previous week. Context Therapeutics Inc. employs 1 staff and has a market cap (total outstanding stock value) of $23 million.
How to buy shares in Context Therapeutics Inc.
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – CNTX – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
What's in this guide?
- Can I buy shares in Context Therapeutics Inc.?
- Has coronavirus impacted Context Therapeutics Inc. shares?
- Context Therapeutics Inc. shares summary
- Compare share dealing platforms
- Is Context Therapeutics Inc. stock a buy or sell?
- Context Therapeutics Inc. performance over time
- Context Therapeutics Inc.'s financials
- Does Context Therapeutics Inc. pay a dividend?
- Other common questions
Context Therapeutics Inc. stock price (NASDAQ:CNTX)Use our graph to track the performance of CNTX stocks over time.
Context Therapeutics Inc. shares at a glance
|Latest market close||$2.10|
|52-week range||$1.83 - $252.00|
|50-day moving average||$4.00|
|200-day moving average||$4.46|
|Wall St. target price||N/A|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-6.11|
Compare online stock trading platforms
Note: The dollar amounts in the table below are in Canadian dollars.
Is it a good time to buy Context Therapeutics Inc. stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Context Therapeutics Inc. price performance over time
|1 week (2022-01-14)||-6.67%|
|1 month (2021-12-22)||-33.75%|
|3 months (2021-10-22)||-69.96%|
|6 months (2021-07-21)||-98.85%|
|1 year (2021-01-22)||-98.92%|
|2 years (2020-01-22)||-99.38%|
|3 years (2019-01-22)||5.00%|
|5 years (2017-01-20)||800|
Context Therapeutics Inc. financials
|Gross profit TTM||$0|
|Return on assets TTM||0%|
|Return on equity TTM||0%|
|Market capitalisation||$23 million|
TTM: trailing 12 months
Context Therapeutics Inc. share dividends
We're not expecting Context Therapeutics Inc. to pay a dividend over the next 12 months.
Context Therapeutics Inc. overview
Context Therapeutics Inc. , a clinical-stage biopharmaceutical company, develops products for the treatment of cancer for women in the United States. Its lead product candidate is onapristone extended release (ONA-XR), a selective potent antagonist of the progesterone receptor that is linked to resistance for various classes of cancer therapeutics, such as ovarian, uterine (endometrial), and breast cancers. The company also engages in developing CLDN6xCD3 bsAb, an anti-CD3 x anti-Claudin 6 antigen bispecific monoclonal antibody that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6. In addition, it is involved in the development of Sigma1, a cellular protein that regulates homeostasis, which is in clinical studies for the treatment of breast and prostate cancer. The company has a collaboration and licensing agreement with Integral Molecular, Inc. for the development of CLDN6xCD3 bsAb.
Stocks similar to Context Therapeutics Inc.
Context Therapeutics Inc. in the news
Markets are expected to remain on edge as the Fed meets in the week ahead
Netflix quietly admits streaming competition is eating into growth
Microsoft's $68.7 billion deal for Activision once again shows big tech's dominance over legacy media
Frequently asked questions
More guides on Finder
How to buy Aritzia stock in Canada
Steps to owning and managing Aritzia (ATZ) stock, with 24-hour and historical pricing before you buy.
CI Direct Trading review
Get low fees and access many different types of accounts, platforms and investments with this reputable online broker.
Kusama (KSM) price prediction
Read our expert analysis on Kusama and how the token will perform in the future.
How to buy The Sandbox (SAND) in Canada
This guide provides step-by-step instructions on how to buy The Sandbox, lists some exchanges where you can get it and provides daily price data on SAND.
COVID testing stocks
We’ve rounded up stats on some of the most popular COVID testing stocks, along with information on how they compare and how to invest.
Shiba Inu (SHIB) price, history and performance
This guide explores the different ways of buying Shiba Inu on a cryptocurrency exchange as well as where you should store your cryptocurrency.
Baby Doge Coin (BABYDOGE) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Baby Doge Coin, lists some exchanges where you can get it and provides daily price data on BABYDOGE.
Pendle (PENDLE) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Pendle, lists some exchanges where you can get it and provides daily price data on PENDLE.
Hempcoin (THC) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Hempcoin, lists some exchanges where you can get it and provides daily price data on THC.
The ChampCoin (TCC) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy The ChampCoin, lists some exchanges where you can get it and provides daily price data on TCC.
Ask an Expert
You must be logged in to post a comment.